MMP9 and non-small cell lung carcinoma: In, 2019, it was reported that ethyl pyruvate (EP) reduces MMP9 levels and attenuates the migration and invasion of non-small cell lung cancer (NSCLC) cells by inhibiting the HMGB1/RAGE axis (82).